हिंदी में पढ़ें

Sun Pharmaceutical Industries

Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018

Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018

Mon, Dec 31, 2018

The sector has been volatile throughout the year due to constant news flow in the markets. Some giants of the sector witnessed objections over their manufacturing plants and medicine pricing in the U.S. markets.

Sun Pharma Q2 net loss at Rs 219 cr due to provisions for US antitrust case

Sun Pharma Q2 net loss at Rs 219 cr due to provisions for US antitrust case

Tue, Nov 13, 2018

Drug major Sun Pharmaceutical Industries Tuesday reported a consolidated net loss of Rs 218.82 crore for the July-September quarter on account of a Rs 1,214-crore provision for the settlement of the Modafinil antitrust case in the US.

Sun Pharma first-quarter profit beats estimates as U.S. sales climb

Sun Pharma first-quarter profit beats estimates as U.S. sales climb

Tue, Aug 14, 2018

In the year-ago quarter, Sun Pharma incurred costs of 9.51 billion rupees related to settlements in a U.S. antitrust case over sleep disorder drug Modafinil.

TRENDING NOW

Post GST domestic pharma companies to face headwinds in 1HFY18

Post GST domestic pharma companies to face headwinds in 1HFY18

Mon, Jun 05, 2017

It has been a long and dreary quarter for pharmaceutical companies in Q4 wherein most posted a decline in net profit and things are not looking too good for the Indian pharma companies in the first half of FY18 as well.

Sun Pharma says sales may fall in 2018 as US market gets tougher for generic drugs

Sat, May 27, 2017

Sun Pharmaceutical Industries MD Dilip Shanghvi has said on Friday that the US sales might fall in 2018 because of pressure on drug prices, signalling tough market conditions in the United States (US) for generic drugmakers.

Earnings, global cues to set trend this week; stocks may see volatility

Earnings, global cues to set trend this week; stocks may see volatility

Sun, May 21, 2017

Indian stock markets this week are likely to witness volatility in the midst of derivatives expiry, global cues alongwith quarterly earnings of blue-chips such as Tata Motors, ITC, and Sun Pharma.

Reliance Industries' Mukesh Ambani tops Indian billionaire list in Forbes survey; see full list

Reliance Industries' Mukesh Ambani tops Indian billionaire list in Forbes survey; see full list

Tue, Mar 21, 2017

Reliance Industries' chairman and MD Mukesh Ambani has topped the list of Indian billionaires featured in Forbes recent survey titled 'The World's Billionaires' with global ranking of 33 and networth of $23.2 billion, find out names of other Indians in the list.

Sun Pharmaceutical Industries' Q3 net profit falls nearly 5% to Rs 1,471.82 crore

Sun Pharmaceutical Industries' Q3 net profit falls nearly 5% to Rs 1,471.82 crore

Tue, Feb 14, 2017

Sun Pharmaceutical Industries consolidated net profit fell down by 4.73% to Rs 1,471.82 crore for the October to December quarter of fiscal year 2016-17 (FY17).

Sun Pharma recalls 2.7 lakh bottles of antidepressant in US

Sun Pharma recalls 2.7 lakh bottles of antidepressant in US

Sun, Feb 05, 2017

The recall is being initiated by Sun Pharmaceutical Industries Inc for 2,71,212 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strengths of 150 mg and 200 mg, US Food and Drug Administration (USFDA) said in its latest Enforcement Report.

India Post Payments Bank starts pilot services in Raipur & Ranchi

India Post Payments Bank starts pilot services in Raipur & Ranchi

Mon, Jan 30, 2017

India Post has started operations of its payments bank on Monday on pilot basis in Raipur and Ranchi.

Sun Pharma Q2 net profit rises by 90%; India sales up by 11%

Sun Pharma Q2 net profit rises by 90%; India sales up by 11%

Fri, Nov 11, 2016

Pharma-giant Sun Pharma reported consolidated net profit of Rs 2471.11 crore for the second quarter September 30, 2016, recording robust rise of 90.20% year-on-year (yoy) and 8.96% quarter-on-quarter (qoq).

What would a Hillary Clinton win mean for Indian Pharma?

What would a Hillary Clinton win mean for Indian Pharma?

Mon, Nov 07, 2016

The global generics sector saw a significant de-rating in YTD (year-to-date) in the CY2016 with 1-year forward P/E (price over equity) contracting by 34%, with the past one month itself witnessing an 11%.

Pharma stocks fall sharply as US drug pricing investigation nears completion

Pharma stocks fall sharply as US drug pricing investigation nears completion

Fri, Nov 04, 2016

Media reports suggest that the US Congress investigation into price hikes, that began in October 2014, may be nearing completion, culminating into charges of price collusion against companies / individuals by the year end.

Sensex falls on fears drug makers may be charged in US probe

Sensex falls on fears drug makers may be charged in US probe

Fri, Nov 04, 2016

Indian shares fell to their lowest in nearly four months on Friday, led by drug makers, after Bloomberg reported that US prosecutors could file charges by year-end in a criminal investigation of generic makers over suspected price collusion.

Sun Pharma launches sunscreen brand Suncros

Wed, Jun 08, 2016

The company will focus on dermatology as the fourth engine of growth for its OTC business, Sun Pharma said in a filing to the Bombay Stock Exchange (BSE).

Sun Pharma divests two US-based manufacturing units to Frontida BioPharm

Sun Pharma divests two US-based manufacturing units to Frontida BioPharm

Sun, Jun 05, 2016

The US-based firm has also agreed to offer employment to all production, quality and administrative personnel at the sites.

Aurobindo Pharma reports 40% rise in Q4; stocks up 4%

Aurobindo Pharma reports 40% rise in Q4; stocks up 4%

Tue, May 31, 2016

The company's net profit for the January-March quarter rose to Rs 5.63 billion ($83.9 million) from Rs 4.03 billion a year earlier, Aurobindo said in a statement late on Monday.

Sun Pharma shares down 5% post forecast of lower FY17 annual sales

Sun Pharma shares down 5% post forecast of lower FY17 annual sales

Tue, May 31, 2016

India's Sun Pharmaceutical Industries issued a weaker-than-expected annual sales outlook as it grapples with increased competition in the United States (US) as well as supply constraints, sending its shares 5% lower.

US Department of Justice issues grand jury subpoena to Sun Pharma

US Department of Justice issues grand jury subpoena to Sun Pharma

Sat, May 28, 2016

"One of the company's US subsidiaries, Sun Pharmaceuticals Industries Inc (SPII), has received a grand jury subpoena from the United States Department of Justice (DoJ), anti-trust division...," the company said in a Bombay Stock Exchange (BSE) filing.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x